CN110432912A - Therapeutic device, method and system comprising piston type detector - Google Patents
Therapeutic device, method and system comprising piston type detector Download PDFInfo
- Publication number
- CN110432912A CN110432912A CN201910368706.6A CN201910368706A CN110432912A CN 110432912 A CN110432912 A CN 110432912A CN 201910368706 A CN201910368706 A CN 201910368706A CN 110432912 A CN110432912 A CN 110432912A
- Authority
- CN
- China
- Prior art keywords
- lid set
- switch
- lid
- pen
- axis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 23
- 230000001225 therapeutic effect Effects 0.000 title description 2
- 239000003814 drug Substances 0.000 claims abstract description 45
- 229940079593 drug Drugs 0.000 claims abstract description 40
- 238000003756 stirring Methods 0.000 claims abstract description 14
- 238000004891 communication Methods 0.000 claims description 42
- 238000011282 treatment Methods 0.000 claims description 33
- 239000012491 analyte Substances 0.000 claims description 19
- 238000007789 sealing Methods 0.000 claims description 8
- 230000005540 biological transmission Effects 0.000 claims description 6
- 239000000314 lubricant Substances 0.000 claims description 2
- 230000002209 hydrophobic effect Effects 0.000 claims 1
- 230000008054 signal transmission Effects 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 103
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 102
- 239000008103 glucose Substances 0.000 description 101
- 229940125396 insulin Drugs 0.000 description 53
- 102000004877 Insulin Human genes 0.000 description 49
- 108090001061 Insulin Proteins 0.000 description 49
- 238000002347 injection Methods 0.000 description 29
- 239000007924 injection Substances 0.000 description 29
- 210000004369 blood Anatomy 0.000 description 27
- 239000008280 blood Substances 0.000 description 27
- 238000012937 correction Methods 0.000 description 17
- 102000016261 Long-Acting Insulin Human genes 0.000 description 10
- 108010092217 Long-Acting Insulin Proteins 0.000 description 10
- LEMUFSYUPGXXCM-JNEQYSBXSA-N caninsulin Chemical compound [Zn].C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3N=CN=C3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1C=NC=N1 LEMUFSYUPGXXCM-JNEQYSBXSA-N 0.000 description 10
- 206010012601 diabetes mellitus Diseases 0.000 description 8
- 102000007327 Protamines Human genes 0.000 description 7
- 108010007568 Protamines Proteins 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 229940048914 protamine Drugs 0.000 description 7
- 230000008859 change Effects 0.000 description 6
- 238000007726 management method Methods 0.000 description 6
- 210000000496 pancreas Anatomy 0.000 description 6
- 206010022489 Insulin Resistance Diseases 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 229940127560 insulin pen Drugs 0.000 description 5
- 230000001568 sexual effect Effects 0.000 description 5
- 238000007920 subcutaneous administration Methods 0.000 description 5
- 241001269238 Data Species 0.000 description 4
- 241000219095 Vitis Species 0.000 description 4
- 235000009754 Vitis X bourquina Nutrition 0.000 description 4
- 235000012333 Vitis X labruscana Nutrition 0.000 description 4
- 235000014787 Vitis vinifera Nutrition 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000004980 dosimetry Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000012806 monitoring device Methods 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 201000001421 hyperglycemia Diseases 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- 240000008415 Lactuca sativa Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000712 assembly Effects 0.000 description 2
- 238000000429 assembly Methods 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 235000021152 breakfast Nutrition 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 235000012045 salad Nutrition 0.000 description 2
- 230000002123 temporal effect Effects 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000005156 Dehydration Diseases 0.000 description 1
- 208000002230 Diabetic coma Diseases 0.000 description 1
- 206010013647 Drowning Diseases 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 101000976075 Homo sapiens Insulin Proteins 0.000 description 1
- 206010023379 Ketoacidosis Diseases 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- 206010057430 Retinal injury Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000002266 amputation Methods 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 238000004883 computer application Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000001037 epileptic effect Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000003698 laser cutting Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 238000007391 self-medication Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000007514 turning Methods 0.000 description 1
- 238000004078 waterproofing Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Physics & Mathematics (AREA)
- Emergency Medicine (AREA)
- Optics & Photonics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
A kind of pen cap for medication delivery pen includes piston type detector body.The piston type detector body includes at least one inner casing, includes the first open end, the medication delivery pen can be inserted by first open end;The second end opposite with the first end;Side wall is limited by outer surface and opposite inner surface;And channel, the inner surface is extended to from the outer surface.The side wall extends between the first end and the second end, thus defines therebetween pen and receives chamber.The piston type detector body further includes at least one switch and a translatable axis being at least partly placed in the channel.The translatable axis includes main body, and the main body at least receives the bonding part in chamber to extend to the switch engaging portion in the pen receiving chamber from the pen.The translatable axis is oriented at during medication delivery pen is covered into the inner casing and advances at least second position from first position to stir at least one described switch.
Description
Technical field
The present invention relates to the device, method and system comprising piston type detector.In a particular embodiment, piston type detects
Device can be located in the lid set of the dosage administration set such as medication delivery pen.Device, method and system presented herein can
Collect about from dosage administration set remove and/or replace lid set time data, the time data so as to determination control
Treat setting and/or treatment recommendations.
Background technique
Diabetes be it is a kind of due to human insulin hyposecretion cause human body can not normal absorption sugar chronic metabolic
Disorders.This hypoinsulinism leads to hyperglycemia, i.e., there are excessive glucose in blood plasma.Long term hyperglycemia
Disease can lead to the long-term complications of a variety of serious symptoms and threat to life, for example, dehydration, ketoacidosis, diabetic coma,
Cardiovascular disease, chronic renal failure, retinal damage and neurotrosis and its subsidiary amputation risk.Treat glycosuria
The typical method of disease is Blood glucose self-monitoring and insulin self medication.However, " correct " dosage of insulin is in blood
Glucose content and become.Insulin dose deficiency can lead to hyperglycemia, and excessive insulin dose can lead to hypoglycemia.
Hypoglycemia can lead to clumsy, difficult to speak, the clouding of consciousness, loss of consciousness, epileptic attack or death.Therefore, diabetic
(PWD) sizable cognitive load is faced when determining whether insulin dose is appropriate.
The treatment data for collecting PWD can be used for improving Treatment decsion, therefore reliable and powerful data gathering tool is people
Need.
Summary of the invention
In one embodiment, a lid set for medication delivery pen includes piston type detector body.The piston
Formula detector body includes at least one inner casing, includes the first open end, the medication delivery pen can pass through described first
Open end insertion;The second end opposite with the first end;Side wall is limited by an outer surface and an opposite inner surface
It is fixed;And channel, the inner surface is extended to from the outer surface.The side wall is in the first end and the second end
Between extend, thus define therebetween pen receive chamber.The piston type detector body further includes at least one switch
The translatable axis being at least partly placed in the channel with one.The translatable axis includes main body, and the main body is at least
The bonding part in chamber is received to extend to the switch engaging portion in the pen receiving chamber from the pen.It is described to put down
Shifting axis, which is oriented at, advances at least second position from first position during medication delivery pen is covered into the inner casing to dial
At least one dynamic described switch.
In one embodiment, a capping method for detecting medication delivery pen includes: medication delivery pen lid is entered
In lid set comprising the piston type detector body;During capping, the movement of medication delivery pen is passed to described
The translatable axis of piston type detector body, so that the switch engaging portion and switch interaction promote to dial
Move the switch.
In one embodiment, a system includes: the lid set comprising the piston type detector body;It is covered with lid
The analyte sensor system of communication, wherein the analyte sensor includes: blood glucose meter, dynamic glucose monitoring devices connect
Continuous glucose monitoring devices and the mobile computing device that can be carried out wireless communication with the lid set.
Other advantages of the part of embodiment will be set forth in the description below, and extra section can understand from the description, or can
It is learnt by practicing embodiment.By combining the element pointed out in the appended claims, advantages of the present invention can be achieved
And it obtains.
It is discussed above and described in detail below merely illustrative and solve the relevant technologies in technical field, therefore not
It should be considered as the limitation to scope of the claims.
Detailed description of the invention
Institute's attached drawing as part of this specification illustrates the embodiment of teachings of this disclosure, and describes one with described
It rises to illustrate present patent application principle disclosed.
Figure 1A illustrates a diabetes-management system, may include described herein including lid set, injection of insulin
The embodiment of pen, glucose sensor and mobile device.
Figure 1B shows blood-sugar content and the user how PWD detects PWD on arm using glucose sensor
How using the lid set having been fixed on Semilente Insulin pen, the embodiment comprising covering set as described in this article, from grape
Sugared sensors for data.
The lid that Fig. 1 C to 1E shows one embodiment is covered when for example covering or going lid, can show example on lid set display
Such as time, recommended doses and canteen suggestion information.
Fig. 2 shows an exemplary communication frameworks for system in Figure 1A.
Fig. 3 A to 3D is the perspective view of the lid set comprising piston type detector body of the invention, and Fig. 3 C is top side view
(close up view comprising piston type detector), Fig. 3 D are bottom side view (close up view comprising piston type detector).
Fig. 3 E is the inner casing section view of the lid set shown in Fig. 3 A to 3D.
Fig. 4 A to 4B is the piston type detector body when the medication delivery pen with syringe needle is inserted into the lid set of embodiment
Movable section view.
Fig. 5 A to 5B is the piston type detector machine when the medication delivery pen of not no syringe needle is inserted into the lid set of embodiment
The movable section view of structure.
Fig. 6 A to 6C is to contain at least two near-field communication (Near Field Communication, NFC) in embodiment
The perspective view of the different degrees of details of the lid set of antenna.
Fig. 6 D is the perspective view of double NFC antennas in the lid set for can be used for Fig. 6 A to 6C.
Fig. 7 A to 7B shows how PWD uses glucose sensor (Fig. 7 A) or its left arm (figure B) on right arm,
To detect the blood-sugar content of PWD and how user is fixed on Semilente Insulin pen using the lid set in Fig. 6 A to 6C and comes up
Data are obtained from glucose sensor.
It is worth noting that, the relevant technologies in for a better understanding of the present invention, the attached drawing in the disclosure has done simplification
And the attached drawing in the disclosure does not strictly observe structure accuracy, details and ratio.
Specific embodiment
Embodiment of the disclosure is described in detail with reference to the drawings, section Example shows in the accompanying drawings.Identical attached drawing is compiled
Number identical or corresponding component will be referred to as much as possible.
Although being used to state the widely applied numberical range of embodiment and parameter being approximation, given in specific example
Numerical value out is reported as precisely as possible.But any numerical value has it centainly to be missed caused by testing measurement Plays difference
Difference.In addition, all ranges in the disclosure are interpreted as covering any and all subranges included in it.For example,
The range of " less than 10 " may include any and institute of between minimum value of zero and maximum value 10 (and including minimum value and maximum value)
There is subrange, that is to say, that any and all subranges are with the minimum value equal to or more than zero and most equal to or less than 10
Big value, such as 1 to 5.In some cases, as negative value can be presented in the numerical value for parameter states.In this situation, " it is being less than
Numerical value in 10 " range can be negative value, such as -1, -2, -3, -10, -20, -30 etc..
Merely for illustrative purpose, following embodiment is described with reference to the accompanying drawings.Those skilled in the art will be appreciated that following tool
Body is described as the description to non-limiting exemplary embodiment, and can be in the feelings for not departing from the scope of embodiments of the invention
It modifies under condition to parameter set forth herein.This specification and example should not be limiting, and be only embodiment
Example.It between different embodiments and does not have to be mutually exclusive, some embodiments can be combined with one or more of the other embodiment to be formed
New embodiment.It may include other features it will be understood that the structure shown in attached drawing has simplified, while the knot shown in attached drawing
Structure can be removed or altered.
Any technology appropriate can be used to obtain pen and cover information in lid set in the disclosure.In some cases, this public affairs
Lid set in opening can have a piston type detector body, and the piston type detector body includes piston, and the piston prolongs
Injection pen is received in inner casing and contacted when injection pen is inserted into lid set to the injection pen for reaching lid set, and is fastened in lid set
Against switch press when injection pen.
In the disclosure in the exemplary embodiment of provided Case management system, lower Figure 1A illustrates diabetes management
System 10, diabetes-management system 10 include insulin injection pen 110 and 120, glucose sensor 130 and mobile device
140.Mobile device can be any suitable computer application equipment, such as smart phone or tablet computer.Mobile device can
Storage and carry out mobile applications be used for show from the other component wireless receivings of diabetes-management system to associated treatment believe
Breath.
As shown, each insulin injection pen 110 and 120 includes corresponding lid set 112 and 122, each lid set is respective
Include button and display.It is shown in Fig. 1 go out embodiment in, novopen can be on the market containing any suitable
The mechanical novopen of insulin, suitable insulin include that protamine zine insulin and Semilente Insulin (sometimes referred to as imitate pancreas islet fastly
Plain or ultrafast Semilente Insulin).Can be used as Semilente Insulin has HumalogTM、NovologTM、ApidraTMAnd FiaspTM。
Can be used as protamine zine insulin has LantusTM、LevemirTM、ToujeoTMAnd TresibaTM.As shown, injection of insulin
110 representativenesses of pen illustrate a protamine zine insulin pen, while 120 representativeness of insulin injection pen illustrates a quick-acting pancreas islet
Plain pen.
As shown, lid set 112 and 122 can have unique color, shape or other physical or digitized difference
Feature, to assist diabetic (PWD) to distinguish long-acting lid set 112 and quick-acting lids set 122.Lid set can be with mobile device 140
Wireless communication, so that the data from lid set can be received and be shown by mobile applications.
Glucose sensor 130 can be any suitable glucose sensor, such as blood glucose meter (BGM) and dynamic grape
Sugared sensor or continuous glucose sensor (CGM).In some cases, glucose sensor can pass through reader device
(for example, using NFC communication) is wirelessly transmitted data when reading data.In some cases, glucose sensor 130 can make
Data are wirelessly transmitted at a predetermined interval (for example, using radio frequency) with any suitable communication standard (for example, BLE).
In some cases, a variety of communication technology transmission glucose datas can be used in glucose sensor 130.In some cases, it moves
One or more of dynamic device 140 and/or insulin injection pen or lid set may include NFC reader.When in glucose sensing
When in the interrogating range of device, the NFC reader is applicable to obtain blood glucose level data.In some cases, mobile device 140
And/or insulin injection pen 110,120 or lid set one or more of 112,122 can wireless receiving with predetermined time interval
The blood glucose level data that (for example, per minute, every 5 minutes etc.) are broadcasted from glucose sensor 130.
When using example diabetes-management system 10, PWD (or its caregiver) can be responsible for determining when insulin injection
With injection how much insulin, but system 10 can according to from glucose sensor current data, joined according to the treatment that is stored
It counts and/or PWD (or caregiver) is assisted to determine insulin dosage appropriate according to the related data of injection of insulin.One
Under a little situations, the data that lid set can reflect according to the piston type detector body in the disclosure are provided about when carrying out
The data of injection of insulin.For example, lid set 112 and 122 can be examined by the piston type detector body in the disclosure
The time that each lid set is applied to its insulin injection pen again is surveyed, this time can be considered injection time.In some situations
Under, lid set 112 and 122 can pay attention to the insulin surplus in insulin injection pen and can determine each injection of insulin
Amount.It can be with reference to the 62/599,963rd and No. 62/648,064 beauty of the co-pending being incorporated herein by reference
In state's patent application, and the disclosed patent and application number WO 2017/009724 that are incorporated herein by reference
A1;US 8,817,258 B1;With described in 2,987 518 B1 of EP.
Figure 1B illustrates how glucose sensor 130 can be applied to its arm by PWD 20, to detect the blood of PWD
How sugared content and user can be read using the lid set 122 for being fastened to Semilente Insulin pen 120 from glucose sensor 130
Access evidence.Before or after user slides the set of the lid in Figure 1B 122, lid set 122 can show associated treatment information.One
Under a little situations, associated treatment information may include the information about the one or many insulin injected recently, glucose data and
/ or one or more insulin dose suggestion.For example, lid set 122 can show nearest pancreas islet before or after sliding
The time of plain medication.In some cases, in lid set 122 before the sliding of glucose sensor 130, lid set 122 can be shown
For the insulin dose suggestion for not including correction component of canteen.In some cases, in lid set 122 adjacent to glucose sensing
After device 130 slides, lid set 122 can show correction insulin dose suggestion or be directed to canteen and include the insulin for correcting component
Dosage suggestion.
For example, the display 124 on lid set 122 is illustrated in Fig. 1 C, can show nearest medication or " last time is used
Medicine " the time 125.Time 125 can assist user to recall whether they have been the used medicament of nearest canteen and/or have helped to use
Family avoids unexpected repeated drug taking.In some cases, such as when lid set is capable of detecting when dosage, display can be additional
Show last time dosage value.In some cases, last administration time can indicate the last use of distance with a clock
How long medicine has passed.In some cases, display can show the blood-sugar content measured recently and time of measuring.
In some cases, display can be electronic ink display.In some cases, display may include identification information (example
Such as the name of user, such as the mark of " pen of Sarah (Sarah) ") and/or its novopen type information (for example, pancreas islet
The brand of element).
Fig. 1 D illustrates the lid set 122 that blood glucose level data 129 is presented.Blood glucose level data 129 may include current blood glucose content and blood
Sugared content trend arrow, blood-sugar content trend arrow can be after lid set cover as shown in fig. 1b from glucose sensor 130
It receives.Fig. 1 D also includes that correction dose suggests 127d and corresponding correction dose icon 126d.
Fig. 1 E illustrates the lid set 122 for suggesting 127a to 127c with canteen dosage, and the suggestion of canteen dosage can be according to meal
Different size of canteen represented by food icon 126a to 126c provides.Additionally or alternatively, user can be to canteen icon 126a
Personal settings are carried out to 126c to indicate different types of canteen (for example, B, L, D label are used to refer to breakfast, lunch, evening
The picture of meal or canteen type, such as salad icon, sandwich icon and macaroni icon).For example, in use,
After the display for seeing Fig. 1 D, user can be obtained canteen dosage suggestion by lower button 123.In some cases, canteen
The setting value that dosage suggestion can be arranged during setting using mobile applications based on health care professionals, PWD or caregiver
It provides, or the updated value of the canteen dosage updated by health care professionals, PWD or caregiver provides.In some cases, it eats
The individual subscriber dosimetry parameter that food dosage suggestion can be automatically updated according to system using any suitable algorithm provides.One
Under a little situations, when (for example, in last 5,10,15,20 or 30 minutes) read blood-sugar content to user recently, canteen dosage is built
Discussing 127a to 127c can be simultaneously comprising both canteen dosage and correction dose.In some cases, if lid set 122 has identified
Other nearest administration times are (for example, dynamic by the capping of the lid set in detection last 3 hours, last 4 hours or 5 hours last
Make), and it is unaware of dosage, lid set is rejected by addition correction component, repeats to take correction medicament to prevent unexpected.Some
Under situation, canteen icon 126a to 126c may indicate that whether canteen dosage suggests comprising correction component.In some cases, may be used
Using additional icon or display data instruction canteen dosage suggest whether include correction dose suggestion and/or suggestion correction
The number of dosage.In some cases, by pressing lower button 123, user can be seen display and show current blood glucose value, trend
Information (for example, trend arrow) and the correction dose suggested.In some cases, if the nearest medication (example of existing insulin
Such as, in last 1,2,3 or 4 hour), correction dose suggestion may occur in which warning warning medication recently near or over, thus anti-
It is only unexpected to reuse insulin.In some cases, notification icon 128 can be presented on lid set 122, to indicate to the user that
User can get more detailed suggestion, prompt, warning or alarm in the mobile applications in mobile device 140.
Lid set 112 and 122 and the disclosure provided in other methods, devices and systems can be simple and easy mentioned for user
For treatment relevant information and/or treatment recommendations, while and/or collecting and pen is used to cover information.
Lid set 112 and 122 can be configured to fill with one or more glucose sensors and/or one or more mobile computing
Set wireless communication.In some cases, lid set provided in the disclosure may be adapted to wirelessly receive Portugal from glucose sensor
Grape sugar data and glucose data is transmitted wirelessly to mobile computing device from glucose sensor.In some cases, originally
Lid set provided in open the first wireless communication technique can be used to receive glucose data from glucose sensor and use the
Glucose data is transferred to mobile computing device by two wireless communication techniques.In certain situations, compared to the second communication skill
Art, the first wireless communication technique can have closer expected communication range.In some cases, user must use first to lead to
Letter technology obtains glucose data from glucose sensor, while carrying out glucose data automatically via second communication technology
Transmission.In some cases, Gai Taoyu glucose sensor 130 using NFC communication and user must will lid set close to subcutaneously
The glucose sensor 130 for being implanted into human body obtains glucose data.In some cases, lid set can make with mobile computing device
It is communicated with BLE.BLE communication can trigger at regular intervals and/or receive glucose data from glucose sensor in lid set
Automatic trigger later.In some cases, also any suitable technology can be used to connect from glucose sensor for mobile device 140
It receives glucose data and glucose data can be transferred to lid set 112 or 122 from mobile computing device 140.In some situations
Under, glucose data may include that lid can be made to cover to prolong at one from the single transmission that glucose sensor is transferred to lid set
The data of at least two glucose estimation values (EGV) are determined between long at least 30 minutes in section.In some cases, once
Data single transmission may include at least 1 hour glucose data, at least 2 hours glucose datas, at least 4 hours Portugals
Grape sugar data, at least 6 hours glucose datas, or at least 8 hours glucose datas.
Lid set 112 and 114 may include one or more processors and memory, for controlling wireless communication, control user
Interface and/or determining treatment recommendations.In some cases, lid set provided in the disclosure may include processor and be associated
Memory, can determine EGV value from sensor raw data together with algorithm.In some cases, glucose sensor
EGV value can be transmitted.In some cases, lid set provided in the disclosure may include that memory is used to store individual subscriber agent
Parameter is measured (for example, the daily dose suggestion of protamine zine insulin or daily total basic dosage (TDBD), insulin sensitivity sexual factor
(ISF), carbohydrate-insulin ratio (CR), daily total insulin dose (TDD), target glucose value etc.).Some
Under situation, individual subscriber dosimetry parameter can be time or day relevant parameter, such as CR and ISF value with the daily time
And change.In some cases, lid set provided in the disclosure can have memory to be used to store for different canteens or needle
Semilente Insulin dosage suggestion to different canteen classifications.In some cases, individual subscriber dosimetry parameter and/or for not
Various dose suggestion with canteen can be updated via the mobile computing device with lid set wireless communication.For example, mobile computing
These parameters or dosage suggestion may be updated in algorithm in device or cloud.In some cases, parameter or dosage suggestion can be by
Health care professionals are updated or are updated manually by PWD or caregiver.In some cases, lid set may include that a kind of algorithm is covering
It covers in memory, the algorithm updates individual subscriber dosimetry parameter or dosage suggestion after being executed by processor.
In some cases, lid set provided in the disclosure can be based on from Continuous Glucose monitor, flash glucose
The glucose data that monitor, blood glucose meter or any other suitable glucose sensor receive is shown to user or with it
Its mode informs user's current blood glucose content and/or blood glucose trend data (for example, change rate).Lid provided in the disclosure
Set can also be based on blood glucose level data, individual subscriber measuring parameter, the dose suggestion being arranged by user or health care professionals, daily
In time, canteen data or canteen classification or any other suitable input in one or more information provide insulin
Dosage suggestion.
Adding and removing cover information (that is, temporal information that lid set is fastened to injection pen and/or discharges from the injection pen) can wrap
Containing about the current information covered the period (for example, the elapsed time from last cover), about one or many lids that go
Time interval information and every time go lid and cover every time temporal information (for example, daily adding and removing cover the specific time or since
Last adding and removing cover plays elapsed time).In some cases, Gai Taoke displays for a user adding and removing cover information.In some shapes
Under condition, adding and removing cover information can notify user by the loudspeaker in lid set.For example, in some cases, set can provide one
A timer clock timing elapsed time in total from the lid set last time is fastened to injection pen.In some cases, Gai Taoke
Adding and removing cover information is wirelessly passed to mobile device 140 (for example, the smart phone of an operation mobile applications, flat
Plate computer etc.).
Adding and removing cover information can be used to adjust user experience.In some cases, lid set can according to adding and removing cover information come
The user of adjustment for the treatment of relevant information and/or suggestion is presented.For example, in some cases, lid set can be passed according to glucose
The data of sensor, which carry out suggestion, can correct the correction drug dose of raised blood-sugar content, but covering set can be only when adding and removing cover
This correction medicament suggestion is presented in interval when being greater than threshold time period (for example, at least 3 hours, at least 4 hours or at least 5 hours).
In some cases, lid set can provide a user notice, warning or alarm according to adding and removing cover information.For example, if lid
(for example, in 30 minutes or 1 hour) are covered in the threshold time period apart from adding and removing cover time last time to remove from injection pen, that
Lid set can provide sense of vision, audio or with vibration notice to prompt the possible user recently of user to use and be somebody's turn to do
Injection pen insulin injection.In some cases, lid set can be with mobile computing device (for example, smart phone, tablet computer)
The one or more notices generated according to adding and removing cover information, police can be notified or shown in wireless communication and mobile computing device
Announcement or alarm.
It stores, show together, analysis adding and removing cover information and glucose data can determine whether that user behavior, such as this user are
It is no correctly to use insulin for canteen and/or the raised blood-sugar content of correction.In some cases, adding and removing cover letter
Breath can be presented on the blood glucose level data chart of user, and be presented to the user simultaneously and/or health care professionals.In some situations
Under, assessing the blood glucose level data after each adding and removing cover in a period of time can determine whether user correctly uses in adding and removing cover
Insulin and whether user under medication or over administration.
Fig. 2 illustrates the exemplary communication framework for the system in Figure 1A, and illustrates between the component of Figure 1A system
Possible communication link.Various assemblies can be connected with each other via wireless control, NFC or BLE communication protocol.According to specific
Time point ongoing system workflow, each component shows, transmits and receives information in system.As shown, grape
Sugared sensor 130 can be covered via NFC and quick-acting lids 122, communication link 231 and/or with mobile device 140, communication link 232
Communication.In some cases, long-acting lid set 112 can be communicated via NFC communication with glucose sensor 130.In some situations
Under, because the insulin for being used as correction or canteen dosage only has Semilente Insulin, to prevent user from obscuring long-acting lid set 112
It is not communicated via NFC communication with glucose sensor directly.In some cases, glucose sensor 130 can be additionally via nothing
Line electricity is communicated with mobile device, and the radio transmits blood glucose value at a predetermined interval.Lid set 112 and 122 can be logical via BLE
Letter is communicated with mobile device 140.Blood glucose level data, programmed therapy parameter (for example, the daily dose of protamine zine insulin, for difference
Dosage (it can change according to Time of Day), the insulin sensitivity sexual factor, carbohydrate-insulin ratio of canteen size
Deng), adding and removing cover data (can add can be not added by the dose data that detects of lid set) can be in mobile device 140 and each lid set
It is conveyed between 112 and 122, and system data can be passed to network service via WiFi or cellular connection 241 250 (it can be
Any remote server).In some cases, each lid set can configure included processor and memory to execute algorithm
To determine dosage suggestion.In some cases, the practicable treatment recommendations of mobile device or implementation treat parameter more new algorithm to push away
It recommends the change to programmed therapy parameter and/or automatically updates programmed therapy parameter.In some cases, network service 250
Practicable algorithm is to recommend to change and/or automatically update programmed therapy parameter.
In some cases, in the mobile applications on initial treatment parameter programmable to mobile device 140 and via
BLE communication link 211 and 221 is transferred to lid set.In some cases, lid set 122 can be used receives from mobile applications
Treatment parameter correction dose and canteen dosage suggestion are provided.In some cases, treatment parameter may include for different or not
Canteen with size is (for example, small-sized canteen, medium-sized canteen and large-scale canteen;Or breakfast, lunch and dinner;Or salad, Sanming City
Control and macaroni) canteen dosage.In some cases, treatment parameter may include the treatment parameter for correcting blood glucose value, example
Such as insulin sensitivity sexual factor.In some cases, lid set 112 can receive controlling to regulation protamine zine insulin daily dose
Treat parameter.In some cases, lid set 112 can receive the suggestion of protamine zine insulin from mobile device mobile applications 140
It uses time (for example, 9 points of every night, 8 points of every morning, 8 a.m. and at 8 points in afternoon twice a day etc.).
Lid set is also configured to the dosage suggestion that may be followed for understanding user.For example, the such as the 15/717th,
Described in No. 805 U.S. Patent applications, lid set (regardless of whether lid set has the feature for capturing dosage) may include that canteen is logical
The classification (such as S, M, L) known, and the data in each notice can be shown that whether user may be directed to the use of S, M or L canteen
Insulin dose appropriate.No. 15/717,805 U.S. Patent application is incorporated herein by reference.In some shapes
Under condition, the button repeatedly pressed on gland set 122 can show dosage suggestion to S canteen successive later, M canteen and L canteen,
And method and system provided in the disclosure may be assumed that user used pancreas islet according to the preceding dosage suggestion once shown
Element.In some cases, added on mobile applications in different time intervals (once a day, per once a few days,
Weekly) information of insulin residual volume can indicate whether user generally follows treatment recommendations or whether user neglects in pen
The slightly described treatment recommendations.In some cases, method and system provided in the disclosure can by analysis glucose data,
Insulin surplus data and/or the problem of providing in mobile applications, are answered in adding and removing cover information, one or more pens
Case follows a possibility that dosage is suggested or to user's scoring to measure user.Method and system provided in the disclosure can make
With a possibility that the measurement or scoring to determine a need for adjustment dosage suggestion or for user provides guidance.
Method and system provided in the disclosure can be additionally included in and one or more lid set channel radios in the disclosure
Believe the mobile applications run in the mobile device (for example, smart phone or tablet computer) of (for example, via BLE).In
Under some situations, blood glucose level data can be transmitted from glucose sensor via lid set and/or directly be transmitted from glucose sensor.
In some cases, mobile applications can have a user interface to carry out chart display blood glucose level data.In some cases,
One chart for showing blood glucose level data at any time may include the indicant for conveying adding and removing cover information.
In order to collect adding and removing cover information as described above, one is able to detect capping and/or goes to the mechanism of lid that can place
In lid set, such as it is placed in lid set 112 and/or lid set 122.Fig. 3 A to 3D is illustrated (not to be shown to such as medication delivery pen
The lid set 312 that dosage administration set out) uses.In figure 3 a, lid set 312 includes an outer housing 301, and several components can
It is contained in outer housing 301, as shown in Figure 3B.Outer housing 301 may include that first part 301a and second part 301b are connecing
It stitches and is linked together at 302 to limit the first opening 304 and the second opening 306.First part 301a and second part 301b can
It is connected by friction, fastening, welding, gluing, melting or any other suitable adhesive method.In some embodiments, outside
Shell 301 can have integral type space configuration (not shown).
Such as the internal component of display 314 and/or button 309 can be placed in outer housing 301.Display 314 can be with
It is LCD, Electronic Paper, LED, OLED or any other suitable display, can be checked by the opening 308 in outer housing 301
The display.Button 309 can be mechanical spring loaded button, touch reaction button (that is, touch screen and/or tactile are anti-
Answer), user can use button 309 via opening 308 or via single opening.Outer housing 301, first part 301a and/or
Two part 301b may include the class of plastics, metal, any other suitable material, a combination thereof or any other suitable material
One of type is a variety of.Shell can for different transparencies, comprising from substantially transparent (for example, can be seen by shell
Internal component) to being substantially non-transparent (for example, can not see inside by shell).Any suitable system can be used in shell
Process and its material manufacture appropriate are made, such as machining (for example, CNC, turning etc.), increasing material manufacturing are (for example, 3D is beaten
Print), injection-molded, blown-moulding, casting, punching press, laser cutting etc..
As shown in the decomposition view of the lid set 312 shown in Fig. 3 B, piston type detector body 315 is together with display and presses
Button is placed in together in outer housing 301.Display, button and piston type detector body 315 could attach to together, such as shape
At a common element.Common element, which can have, enables each component that can be separately attached to other components or tear open from other components
The modularized design unloaded.For example, display 314, button 309 and piston type detector body 315 may be mounted at for example
In common support base (invisible), and circuit board (invisible), the place can be connected to together with memory and processor
Reason device communicates with memory and is configured to carry out the instruction being stored in memory;And airborne power supply (not shown), such as can
Storage battery.
Piston type detector body 315 includes: inner casing 350, one for being designed to receive insulin delivery pen work as
Insulin delivery pen is fastened on lid and puts on (capping movement) or cover from lid mutual with insulin delivery pen when removing (lid is gone to act)
The piston assembly 360 of effect and for piston assembly will cover or go lid movement be passed to circuit board and finally arrive processing
The electronic circuit 370 of device offer power path.For example, the piston group during medication delivery pen is covering or removes lid
When component 360 and medication delivery pen interact, electronic circuit 370 transmits signal via opening 303.
As shown in Fig. 3 C to 3E, 4A to 4B and 5A to 5B and it is as follows it is middle further describe, inner casing 350 includes pen
Main body fastening part 351, syringe needle fastening part 353 and opening 303, pen can be inserted into pen by the opening 303 and receive chamber
So that piston assembly 360 enters in lid set in (invisible) and channel (invisible).
As shown in the enlarged view of Fig. 3 C to 3E, the inner casing 350 of piston type detector body 315 be can further include and the
The opposite second end 356 in one end 303, and the side wall 358 limited by outer surface 352 and opposite inner surface 354.Side wall 358
Extend between first end 303 and second end 356, receives chamber 351' to limit pen.Second end 356 can further limit needle
Head storage chamber 353'.Channel 355 includes the first opening 355' and the second opposite opening 355 " adjacent to chamber 351'.It is logical
Road 355 enables to be placed at least part that the translatable axis 360 in inner casing slidably passes through inner casing 350.
For example, electronic circuit 370 is including, for example, the piston in combination when medication delivery pen 380 is by 303 insertion of opening
At least one switch 371 workable for part 360.At least one described switch can be the microswitch with toggle arm 371'.
In some embodiments, at least one described switch can be " normally opened " switch, thus when place circuit does not have external action
In the case where carrying out toggle switch, at least one described switch is defaulted as open-loop configuration.In some embodiments, it is described at least
One switch can be " normally closed " switch, thus in the case that place circuit does not have external action to carry out toggle switch, default
For open-loop configuration.
Piston assembly 360 includes the translatable axis 361 that can be at least partially positioned in channel 355.Translatable axis 361
It may include main body, the main body at least extends to its switch engaging portion 362 " from a bonding part 362'.It is as follows further
It is illustrated in greater detail in description and Fig. 4 A to 4B and 5A to 5B, translatable axis 361 is oriented at defeated to drug using lid set
At least second position is advanced to stir at least one switch from first position during sending pen to be covered.Removing, drug is defeated
After sending pen, translatable axis 361 can be configured to back to first position.For example, piston return 363 can be configured to certainly
It is dynamic to make translatable axis 361 back to first position.
Piston type is examined when Fig. 4 A to 4B is illustrated in the lid set that the medication delivery pen for having syringe needle is inserted into embodiment
The section view of the operation of Ce Qi mechanism.As described above, translatable axis 361 can be opened via the first opening 355' and second
Mouth 355 " is slidably positioned in channel 355.As shown in Fig. 4 A to 4B and Fig. 5 A to 5B, defeated to drug using lid set
When pen being sent to be covered or gone lid, translatable axis is oriented from first position and advances at least second position.As shown, living
Filling in return 363 may include spring, and being concentrically placed between the first 355 " and switch engaging portion 361' of opening can
On translation shaft.Translatable axis 361, which slides entirely over channel 355 and enters pen, in order to prevent receives chamber 351', may include limitation
Device 364, such as collar assemblies or integrated shoulder portion, the integrated shoulder portion have the second opening than channel 355
355 " broader diameters.
In addition, the inner casing 350 of outer housing 301 and piston type detector body 315 cooperate with limit at least inner cavity chamber to prevent
Sealing point or any other may endanger can for example be positioned at individually or together it is interior between such as inner casing 350 and outer housing 301
The foreign matter of some components of piston types detector body such as the indoor circuit 370 of chamber and at least one switch 371' enters.Shell
Body 301 can cooperate with inner casing 350 prevents liquid from entering to therefore form waterproof inner cavity chamber in inner cavity chamber, or formation has
The chamber of IPX5 or more preferably (IEC standard 60529) waterproofing grade.Moisture or any other foreign matter are from a receiving compartment in order to prevent
Room 351' enters inner cavity chamber, and sealing element 365 can be placed in 355 " place of the second opening.The sealing element can be protective cover sealing
Part can compress between the first opening 365' and pen 380.Sealing element can also or further include coating, such as coated in work
Sealant and/or lubricant compositions on the surface of the main body of plug.
In embodiment, switch 371 is one detectable, two, three or different configurations.For example, dial type is opened
Two different locations (for example, first position and second position) or three different locations (first, second can be toggled it to by closing 371'
And third).For example, tumbler switch 371' can stir position in the first "off", wherein because lid set and pen do not fasten
Together, so translatable axis is in its original undisturbed position;And tumbler switch 371' can be stirred second
Position, wherein because lid set is fastened on the injection pen without syringe needle, piston traveling first segment distance.Dial type is opened
In addition pass 371' may also be in third and stir position, wherein because lid set is fastened to the injection pen with syringe needle, piston row
Into second segment distance, depending on the configuration of pen, the second segment distance can be first or second distance.
For the foreign matter being inserted into lid set, such as pen, the offers of various contacts may depend on shape, the size of piston
And orientation.For example, in some cases, piston may include having the first section of first external diameter and with second external diameter
The second section so that switch is moved to third and stirs configuration by piston in the case where there is fastening syringe needle, but do not fastening needle
The second configuration is moved in the case where head.In another example, piston can have the length along piston main body from first position
The diameter being gradually reduced to the second position, so that switch can determine the relative depth that pen is inserted into lid set, thus further really
Whether the pen being inserted into surely has syringe needle.The data whether pen of the insertion detected has syringe needle can be used to whether judge user
Syringe needle may be replaced after per injection or carries out multiple injection using same syringe needle.In some cases, what is detected inserts
The syringe needle that the data whether pen entered has syringe needle may be used to determine user re-supplies quantity and/or provides for user about needle
The operation instruction that head is suitably replaced.In embodiment, switch may include proximity sensor detect that translatable axis advances away from
From so that whether distance or medication delivery pen that analysis such as medication delivery pen has been inserted into lid set inner casing are fully inserted into
(that is, fastening) is into the inner casing of lid set.
In embodiment, the channel for translatable axis is arranged parallel to the long axis of inner casing.In embodiment, it is used for
The channel 355 of translatable axis 361 is configured to the long axis of parallel offset inner casing.In embodiment, translatable axis is positioned in parallel
Deviate the central axis (b-b') of inner casing 350 and direction (a-a') uplink in the central axis (b-b') for being parallel to inner casing 350
Into.Therefore, detection pen is covered or drowning is gone to have an impact with the presence or absence of syringe needle on pen.This is because pen and piston type detection machine
Bonding station 383 between structure is at main body shoulder 381.
Similar to the lid set 112 and 122 shown as described above and in Figure 1A to 1E, lid set 312 can be the portion of system
Point, the system further includes the analyte sensor system communicated with lid set (for example, blood glucose meter, dynamic glucose monitoring
Instrument or continuous glucose monitoring devices), and/or can be used to configure the mobile computing device for the treatment of parameter, the treatment parameter includes
For the dosage suggestion of different size of canteen, insulin sensitivity sexual factor, carbohydrate-insulin ratio, long-acting pancreas islet
The generally combination of dosage or information above.Lid set can be wirelessly communicated with mobile computing device, thus will such as administration time data
It is transferred to remote subscriber interface.The wireless communication may include that will cover set to match with analyte sensor system, is arranged or updates
It treats parameter and sends treatment information.The wireless communication may include that will treat information to be sent to cloud, for analyzing, more
New treatment one or more of parameter or combination of the above.The wireless communication also may include that treatment information for example covers data, divides
Analyse the combination of object data or information above.
Lid set may include NFC reader, for reading glucose sensing when in the interrogating range in glucose sensor
The blood glucose level data of device.The blood-sugar content of PWD is detected by the way that glucose sensor to be applied on arm, which can be in grape
The inquiry for being fastened on the lid set of Semilente Insulin pen to start glucose sensor is brandished in the interrogating range of sugared sensor.
Fig. 6 A to 6C illustrates the perspective of the lid set 612 for dosage administration set such as medication delivery pen (not shown)
Figure.As shown, lid set 612 includes outer housing 601, display 614 and inner casing 650 matched with outer housing 601.Inner casing
650 may include: the first open end 603, and pen can be inserted by the first open end 603;The second end opposite with first end 603
656;And side wall, limited by outer surface and opposite inner surface, wherein side wall first end (opening 603) and second end it
Between extend, thus limit pen receive chamber (invisible).First NFC antenna 691 can be configured to receive to be generated by transcutaneous sensor
At least one signal.First NFC antenna 691 can be between shell and the first side of inner casing 650.Meanwhile the 2nd NFC days
Line 693 can be configured to receive at least one signal generated by transcutaneous sensor and be located at the of outer housing 601 and inner casing 650
Between two sides.In an example, inner casing 650 is placed between the first NFC antenna 691 and the second NFC antenna 693.
Also may include for the lid set 612 of medication delivery pen as described in this article: memory (invisible) and storage
(invisible) communication of device and being configured to carry out the processor of instruction being stored in memory and with the processor communication
NFC reader (invisible).
Similar to the lid set 112 and 122 shown in as described above and Figure 1A to 1E, lid set 612 can be system
Part, the system further includes and covers the analyte sensor system that communicates of set (for example, blood glucose meter, dynamic glucose
Monitor or continuous glucose monitoring devices), and/or can be used to configure the mobile computing device for the treatment of parameter, the treatment parameter
Comprising for the dosage of different size of canteen suggestion, insulin sensitivity sexual factor, carbohydrate-insulin ratio, long-acting
The daily dose of insulin or the combination of information above.Lid set can with mobile computing device wirelessly communicate to will such as medication when
Between data be transferred to remote subscriber interface.Wireless communication may include will cover set with analyte sensor system match, setting or more
New treatment parameter and transmission treatment information.Wireless communication may include that will treat information to be sent to one or more points of cloud progress
Analysis, the combination function for updating treatment parameter or above functions.The wireless communication also may include treatment information such as adding and removing cover number
According to the combination of, analyte data or information above.
As shown in Fig. 6 C to 6D, the antenna for covering in set 612 includes to be placed on mutual substratej and by base part
695 the first NFC antennas 691 and the second NFC antenna 693 separated.The substrate includes: base part 695, the first NFC antenna
691 are placed in substrate first part above and the second NFC antenna 693 is placed in the second substrate portions above.Described
One NFC antenna 691 is separated by the first bending or hinged part 697 with base part.Second NFC antenna 693 passes through
Second bending or hinged part 699 are separated with base part.Antenna can be connected to circuit 670 by means of contact 694.It can
By the reinforcer shown at 692 be added to as described in antenna with prevent antenna damage.First NFC antenna 691 and the 2nd NFC
Antenna 693 can be placed on the opposite side of display 614.For example, the first NFC antenna 691 can be placed in display 614
The first side on and the second antenna 693 can be placed in opposite second side of display 614.First NFC antenna 691 and
Two NFC antennas 693 can be oriented to the main display surface for being substantially perpendicular to display 614.For example, the first NFC antenna
691 and second NFC antenna 693 can be oriented respectively or respectively it is substantially parallel with display 614 or with its it is substantially vertical between,
Such as the main display surface relative to display 614 is in the angle of about 0o to about 90o, in about 15o to the angle of about 85o and
It is even in the angle of about 35o to about 65o, the angle comprising being in about 45o.
It should be noted that the feature of above-mentioned middle cover set 312 can be combined with the feature of lid set 612.For example, it is used for dosage
The lid set of medicine device such as medication delivery pen can be simultaneously comprising the piston type detector body for detecting the insertion/removal of pen
And the dual-antenna system with such as the first NFC antenna and the second NFC antenna.Therefore, inner housing 650 may include inner housing
350 any and all features.
The method that Fig. 7 A to 7B illustrates the signal of detection sensor collection, such as an analyte sensor can be used as one
A subcutaneous sensor detects signal.Specifically, this method describe PWD can be how in its right arm (Fig. 7 A) or its left arm (figure
7B) using glucose sensor to detect PWD blood-sugar content and user can be how using being fastened on Semilente Insulin
Lid set in Fig. 6 A to 6C on pen reads data from the glucose sensor on any arm.
Analyte sensor is neighboringly placed on comprising the lid of the first NFC antenna 691 and the second NFC antenna 693 set 612
631.As shown in Figure 7 A, in some embodiments, when lid set is neighboringly placed on the subcutaneous analyte sensor 630 of PWD right arm
When, 691 to the second antenna 693 of first antenna is closer to subcutaneous sensor.In instances, as shown in Figure 7 B, in some embodiment party
In case, when lid set is neighboringly placed on the subcutaneous analyte sensor 630 of PWD right arm, 693 to the one NFC of the second NFC antenna
Antenna 691 is closer to subcutaneous sensor.A NFC reader can be activated to read the first NFC antenna 691 and the 2nd NFC to replace
Antenna 693.Referring to Fig. 6 A to 6C, the first NFC antenna 691 and the second NFC antenna 693 can be located at outer housing 601 and inner casing 350
Between, when lid set 612 is oriented for example in the first orientation relative to analyte sensor 630 (for example, such as Fig. 7 A institute
Show), 691 to the second NFC antenna 693 of the first NFC antenna is for example generated by analyte sensor with the reception of higher signal strength
At least a signal signal strength.Also, when lid set 612 is oriented for example relative to analyte sensor 630 the
When in two orientations (for example, as shown in Figure 7 B), 693 to the first NFC antenna 691 of the second NFC antenna is connect with higher signal strength
Receive the signal strength of at least one signal.
When user holds glucose sensor 630 of 612 scanning of lid set on its right arm " R " as shown in Figure 7A, use
Family can hold lid set 612 and make it have the first orientation.Alternatively, exist when user holds 612 scanning of lid set as shown in fig.7b
When glucose sensor 630 on its left arm " L ", user can hold lid set 612 and make it have the second orientation.In some realities
It applies in scheme, the display information provided by display 614 can rotate automatically.This reads letter with allowing user " face-up "
It is inconvenient to remove the text bring that " inversion " is presented by the display of not automatic rotation function from for breath.Therefore, information is shown
It is on its left arm or on its right arm that direction, which will help the quick identification sensor of user,.
It is selected according to the direction for example stored until opposite side is scanned until glucose sensor in last scanning
The instruction for selecting information display direction is storable in memory and is executed by processor.The instruction can according to user input or
The case where according to sensing, such as the variation of gravity direction that airborne accelerometer is sensed, Lai Shihang.Alternatively, display
614 provide information can not rotate automatically, from the direction but regardless of shell or scanning which arm information keep it is quiet
Only.
Although embodiment referring to one or more embodiment explanations, can not depart from the appended claims
Spirit and scope in the case where change and/or modification are made to illustrated example.In addition, an although spy of embodiment
Determining feature may be disclosed with regard to the only one in several embodiments, but in order to need with it is advantageous any given
Or specific function, the category feature can be combined with one or more of the other feature of other embodiments.
In addition, with regard to using term " including (including, includes) " in detailed description and claims, " having
For (having, has, with) " or the degree of its version, such term is intended to have packet as term "comprising"
Containing property.As used herein, phrase such as A, B and C " one or more of " mean it is any of following: individually
A, B or C;Or two combinations, such as A and B, B and C and A and C;Or the combination of three A, B and C.
Practice in view of this specification and to description disclosed herein, other embodiments will be to those skilled in the art
Member is apparent.This specification and example are exemplary only, and the correct scope and spirit of embodiment are by following following claims
Book indicates.
Claims (23)
1. a kind of lid set for medication delivery pen comprising:
Detector body comprising:
Outer housing;
Inner casing, the inner casing include
First open end is configured as receiving medication delivery pen,
Second end, it is opposite with the first end, and
Side wall, with outer surface and inner surface, the side wall extends between first open end and the second end, with
And
Channel extends through the inner casing,
At least one of electronic circuit switch;And
Translatable axis, is at least partially positioned in the channel and including main body, and the main body at least receives chamber from pen
In a bonding part extend to its switch engaging portion, wherein the translatable axis is oriented from first position and advances at least
The second position is to stir at least one described switch.
It further comprise the first NFC antenna, the second NFC antenna and NFC reader 2. lid according to claim 1 set,
First NFC antenna is configured to receive at least one signal generated by analyte sensor, and first NFC antenna
Between the outer housing and the first side of the inner casing, second NFC antenna is configured to receive at least one by described
The signal that analyte sensor generates, and second NFC antenna be located at the outer housing and the inner casing second side it
Between, the NFC reader is communicated with first NFC antenna and the second NFC antenna.
3. lid set according to claim 1, further comprising:
Display;
Memory;And
The processor communicated with the memory.
4. lid set according to claim 1, wherein the second end of the inner casing, which limits syringe needle, stores chamber.
5. lid set according to claim 4, further comprises limiter, limits the row of the translatable axis
Into.
6. lid set according to claim 4, further comprises spring, the spring positioning is at and peace concentric with the axis
It is placed between the first opening and the switch engaging portion.
7. lid set according to claim 4, wherein the translatable axis deviates the central axis for being parallel to the inner casing
It direction and is travelled upwardly in the side for the central axis for being parallel to the inner casing.
8. lid set according to claim 4, wherein at least one described switch is open type switch.
9. lid set according to claim 4, further comprises sealing element.
10. lid set according to claim 9 can be put down wherein the sealing element includes protection shield closure around described
The pen that extends to for moving axis receives the part in chamber to extend.
11. lid set according to claim 9 or 10, wherein the sealing element includes along the described logical of the translatable axis
Hydrophobic lubricant in road.
12. the lid set according to one in preceding claims, further comprises proximity sensor, wherein described close
Degree sensor is configured to sense the travel distance of the translatable axis.
13. a kind of for detecting the method using the time of medication delivery pen, which comprises
Medication delivery pen is received into receiving compartment room, it is described that chamber is received to be defined by the side wall of lid set;
Translatable axis is engaged into channel, to advance at least second position from first position, to stir in electronic circuit
Switch;
Store the time of nearest toggle switch;And
It calculates since the nearest toggle switch plays elapsed time.
14. according to the method for claim 13, wherein the electronic circuit stirs the switch in the translatable axis
Afterwards by electronic signal transmission to processor.
15. the method according to claim 11, the method comprise the steps that
The time of nearest toggle switch is transmitted to remote subscriber interface;
Show the time of nearest toggle switch.
16. a kind of system comprising:
For the lid set of medication delivery pen, the lid set includes piston type detector body, wherein the piston type detector machine
Structure includes:
Channel extends to inner surface from outer surface,
At least one switch;
Translatable axis is at least partially positioned in the channel, wherein the translatable axis is oriented from first position row
At least second position is entered to stir at least one described switch;
Analyte sensor system is covered with the lid and is wirelessly communicated;And
Remote subscriber interface is covered with the lid and is wirelessly communicated.
17. system according to claim 16, wherein the remote subscriber interface and cloud wirelessly communicate.
18. system according to claim 16, wherein the wireless communication between the remote subscriber interface and the lid set
Include: transmission stir recently the switch time and from the analyte sensor system to the remote subscriber interface to
Few primary reading, and setting or update treatment parameter.
19. system according to claim 17, wherein the wireless communication packet between the remote subscriber interface and the cloud
It includes: reporting the time for stirring the switch recently and from the analyte sensor system to the reading at least once of the cloud,
To be analyzed at least once, treatment parameter is updated.
20. a kind of system comprising:
For the lid set of medication delivery pen, the lid set includes piston type detector body, wherein the piston type detector machine
Structure includes:
Channel extends to inner surface from outer surface,
At least one switch;
Translatable axis is at least partially positioned in the channel, wherein the translatable axis is oriented from first position row
At least second position is entered to stir at least one described switch;And
Remote subscriber interface is covered with the lid and is wirelessly communicated.
21. system according to claim 20, wherein the remote subscriber interface and cloud wirelessly communicate.
22. system according to claim 20, wherein the wireless communication between the remote subscriber interface and the lid set
It include: that the time for stirring the switch recently is transmitted to the remote subscriber interface, and setting or update treatment parameter.
23. system according to claim 21, wherein the wireless communication packet between the remote subscriber interface and the cloud
It includes and reports the time for stirring the switch recently to the cloud, for analyzing at least once, and update treatment parameter.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862667085P | 2018-05-04 | 2018-05-04 | |
US62/667,085 | 2018-05-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110432912A true CN110432912A (en) | 2019-11-12 |
Family
ID=68429250
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910368706.6A Pending CN110432912A (en) | 2018-05-04 | 2019-05-05 | Therapeutic device, method and system comprising piston type detector |
CN201920628596.8U Active CN211094134U (en) | 2018-05-04 | 2019-05-05 | Cover for a dosing device |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201920628596.8U Active CN211094134U (en) | 2018-05-04 | 2019-05-05 | Cover for a dosing device |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN110432912A (en) |
-
2019
- 2019-05-05 CN CN201910368706.6A patent/CN110432912A/en active Pending
- 2019-05-05 CN CN201920628596.8U patent/CN211094134U/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN211094134U (en) | 2020-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11195604B2 (en) | Medicament delivery device | |
EP3040025B1 (en) | Analyte sensing system | |
CN102472735B (en) | Universal test strip port | |
CA2511746C (en) | Drug delivery pen with event notification means | |
ES2671054T3 (en) | Compact physiological monitoring devices in the body | |
US20190239825A1 (en) | Notes and event log information associated with analyte sensors | |
CN102300501B (en) | Multi-function analyte test device and methods therefor | |
JP2021507430A (en) | Treatment support information and / or tracking device and related methods and systems | |
CN102469939B (en) | Implantable sensor device and medical delivery device connectable to such a sensor device | |
WO2014160893A2 (en) | All-in-one analyte sensor in a detachable external mobile device case | |
US20230000350A1 (en) | Systems, devices, and methods for integration of an analyte data reader and medication delivery device | |
CA2669302A1 (en) | Analyte sensor and method of using the same | |
EP3047412B1 (en) | Medical device and method operating same | |
JP2024020586A (en) | Therapy devices, methods and systems including piston-style detector | |
EP3047411A1 (en) | Data management unit for supporting health control | |
CN110432912A (en) | Therapeutic device, method and system comprising piston type detector |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40017415 Country of ref document: HK |
|
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |